ACQUISITIONS - Acquisition Date Fair Value of Consideration Transferred (Details)
$ / shares in Units, $ in Thousands |
May 20, 2020
USD ($)
$ / shares
shares
|
| Business Acquisition [Line Items] |
|
| Share price (in dollars per share) | $ / shares |
$ 3.60
|
| Zyla Life Sciences |
|
| Business Acquisition [Line Items] |
|
| Total number of Company ordinary shares issued (in shares) | shares |
6,369,635
|
| Assertio share price as of May 20, 2020 (in dollars per share) | $ / shares |
$ 3.60
|
| Taxes paid by the Company on behalf of Zyla (in thousands) |
$ 529
|
| Total purchase consideration (in thousands) |
35,086
|
| Zyla Life Sciences | Common Stock |
|
| Business Acquisition [Line Items] |
|
| Fair value issued (in thousands) |
22,931
|
| Zyla Life Sciences | Warrants and Options |
|
| Business Acquisition [Line Items] |
|
| Fair value issued (in thousands) |
$ 11,626
|
| Zyla Life Sciences | Warrants |
|
| Business Acquisition [Line Items] |
|
| Purchase price, number of shares outstanding (in shares) | shares |
3,107,728
|
| Zyla Life Sciences | Warrants | Zyla Life Sciences |
|
| Business Acquisition [Line Items] |
|
| Purchase price, number of shares outstanding (in shares) | shares |
1,243,091
|
| Purchase price, number of shares outstanding, per share (in dollars per share) | $ / shares |
$ 0.0016
|